eFFECTOR Therapeutics

EFTR47

Penny Stock

$0.04arrow_drop_up58.10%$0.01

Penny Stock

EFTR47

$0.04

arrow_drop_up58.10%$0.01

Penny Stock

Performance History

Key Stats
Open	$0.04
Prev. Close	$0.02
EPS	-12.57
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$941.00
PE Ratio	-

	LOW	HIGH
Day Range	0.04	0.04
52 Week Range	0.02	17.90

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-12.57

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About eFFECTOR Therapeutics (EFTR)

eFFECTOR Therapeutics, Inc. (EFTR) is a renowned biotechnology company that specializes in the development of novel small molecule drugs for the treatment of cancer. With a mission to transform the lives of patients, EFTR has been at the forefront of innovative research and clinical advancements. The company's stock price history reflects its strong commitment to value creation and growth. Over the years, EFTR has consistently delivered impressive returns to its shareholders, making it a popular choice among investors.

As a leading player in the biotech industry, EFTR boasts a market cap that speaks to its success and potential. With a substantial market capitalization, the company has the financial resources to fuel its research and development efforts and drive its pipeline forward. This has allowed EFTR to attract top talent and form strategic partnerships with industry leaders, further enhancing its competitive advantage.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Stephen T. Worland Ph.D.
Headquarters: Solana Beach
Employees: 15
Exchange: NASDAQ

Keep an eye on eFFECTOR Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is eFFECTOR Therapeutics's (EFTR) price per share?

The current price per share for eFFECTOR Therapeutics (EFTR) is $0.04. The stock has seen a price change of $0.01 recently, indicating a 58.1% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for eFFECTOR Therapeutics (EFTR)?

For eFFECTOR Therapeutics (EFTR), the 52-week high is $17.9, which is 44.65K% from the current price. The 52-week low is $0.03, the current price is 59.36% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is eFFECTOR Therapeutics (EFTR) a growth stock?

eFFECTOR Therapeutics (EFTR) has shown an average price growth of -6.03% over the past three years. It has received a score of 4 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying eFFECTOR Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is eFFECTOR Therapeutics (EFTR) stock price performance year to date (YTD)?

As of the latest data, eFFECTOR Therapeutics (EFTR) has a year-to-date price change of -99.67%. Over the last three months, the change has been -11.11%. Over the past six months, the figure is -97.73%.

help

Is eFFECTOR Therapeutics (EFTR) a profitable company?

eFFECTOR Therapeutics (EFTR) has a net income of -$35.81M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$33.84M. Furthermore, the EBITDA is -$32.59M.

help

What is the market capitalization of eFFECTOR Therapeutics (EFTR)?

eFFECTOR Therapeutics (EFTR) has a market capitalization of $941. The average daily trading volume is 38.82K, indicating the stock's liquidity and investor engagement.

News

STOCK MARKET NEWS

MANAGEMENT STATEMENTS

MANAGEMENT CHANGES

Jun 24, 2024

eFFECTOR Therapeutics Announces it will Wind Down Operations as it Seeks Strategic Alternatives and Expects to be Delisted from Nasdaq

HEALTH

May 20, 2024

eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer and in Low Grade Serous Ovarian Cancer

EARNINGS RELEASES AND OPERATING RESULTS

May 9, 2024

eFFECTOR Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

CALENDAR OF EVENTS

CONFERENCE CALLS/ WEBCASTS

Apr 9, 2024

eFFECTOR Therapeutics to Participate in Upcoming Investor Conference

Apr 5, 2024

eFFECTOR Therapeutics (EFTR) Plunges 82% as NSCLC Study Fails

NEWS

EARNINGS

PENNY STOCKS